Efficacy and safety of rituximab in pemphigus: experience of the German Registry of Autoimmune Diseases

Abstract

Data collected in this systematic registry indicate that rituximab is an effective and relatively safe adjuvant treatment option for refractory pemphigus. To further extend our knowledge on efficacy and safety of this drug, controlled prospective trials are required.